Related Experiment Video
Updated: May 19, 2026

Induction of Mesenchymal-Epithelial Transitions in Sarcoma Cells
Published on: April 7, 2017
miR-335 promotes cell proliferation by directly targeting Rb1 in meningiomas
Lei Shi1, Dongyi Jiang, Guan Sun
1Department of Neurosurgery, The First People's Hospital of Kunshan Affiliated with Jiangsu University, Suzhou, 215300, People's Republic of China.
Abstract:
Meningiomas, one of the most common benign brain tumors in humans, arise from arachnoid cells in the brain meninges. Our investigations have revealed that miR-335 is a typical microRNA overexpressed in meningiomas in humans. Characterization of the effects of miR-335 overexpression in meningiomas demonstrated that elevated levels of miR-335 increased cell growth and inhibited cell cycle arrest in the G0/G1 phase in vitro; in addition, reduction of the miR-335 levels had the opposite effect on tumor growth and progression. Further, previous studies have shown that the mechanism of effect of miR-335 on the proliferation of meningioma cells is associated with alterations in the expression of human retinoblastoma 1 (Rb1). Our results indicate that miR-335 plays an essential role in the proliferation of meningioma cells by directly targeting the Rb1 signaling pathway. Thus, our results highlight a novel molecular interaction between miR-335 and Rb1, and miR-335 may represent a potential novel therapeutic agent to target the proliferation of meningioma cells.
Insights
MicroRNA-335 (miR-335) overexpression promotes meningioma growth by inhibiting cell cycle arrest. Targeting miR-335 may offer a new therapeutic strategy for these common brain tumors.
Area of Science:
- Neuro-oncology
- Molecular Biology
- Genetics
Background:
- Meningiomas are common benign brain tumors arising from arachnoid cells.
- MicroRNAs (miRNAs) play crucial roles in tumorigenesis.
- miR-335 has been identified as overexpressed in human meningiomas.
Purpose of the Study:
- To investigate the role of miR-335 in meningioma proliferation.
- To elucidate the molecular mechanism by which miR-335 affects meningioma growth.
- To explore miR-335 as a potential therapeutic target.
Main Methods:
- In vitro cell culture experiments to assess cell growth and cell cycle.
- Analysis of miR-335 and human retinoblastoma 1 (Rb1) expression levels.
- Investigation of the regulatory relationship between miR-335 and Rb1.
Main Results:
- Elevated miR-335 levels increased meningioma cell growth and inhibited G0/G1 cell cycle arrest in vitro.
- Reduced miR-335 levels decreased tumor growth and progression.
- miR-335 directly targets the Rb1 signaling pathway, influencing meningioma cell proliferation.
Conclusions:
- miR-335 plays a critical role in meningioma cell proliferation.
- The interaction between miR-335 and Rb1 is a key mechanism in meningioma development.
- miR-335 represents a potential novel therapeutic target for meningioma treatment.
More Related Videos
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Abnormal Proliferation
Negative Regulator Molecules
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitogens and the Cell Cycle
The Ras Gene
Ras is a superfamily...
